Physician profile
Brock A Liden
NPI 1598762692
$452,880.01
in general payments reported to CMS, 2019-2025
50 companies · $69K in 2025
The $69K reported for 2025 was more than what 99% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $28K · 2021: $111K · 2022: $23K · 2023: $75K · 2024: $107K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $193K · Travel and Lodging: $36K · Food and Beverage: $8,944 · Royalty Or License: $5,385 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,140 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000 · Education: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $193,260.72 |
| Travel and Lodging | $36,184.98 |
| Food and Beverage | $8,943.60 |
| Royalty Or License | $5,385.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,140.27 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
| Education | $1,022.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $151,611.14 | 2021-2025 | Ceramentbone Void Filler, Cerament G |
| Kerecis Limited | $138,083.21 | 2019-2022 | |
| Polymedics Innovations INC. | $61,779.51 | 2021-2025 | |
| Orpyx Medical Technologies INC. | $42,952.43 | 2021-2024 | |
| Vilex LLC | $26,663.28 | 2023-2025 | Alphalok |
| Extremity Medical | $13,114.22 | 2020-2025 | Lapidus, Lapidus Plates |
| Sweetbio, INC. | $4,200.00 | 2020 | |
| Smith+Nephew, INC. | $2,880.37 | 2019-2025 | Pico, Collagenase Santyl, Grafix |
| Stryker Corporation | $2,496.04 | 2019-2025 | Hoffmann, Augment Injectable, Graftjacket |
| Medical Device Business Services, INC. | $1,433.83 | 2025 | Na |
| Zimmer Biomet Holdings, INC. | $1,395.46 | 2019-2025 | Gel-One Cross-Linked Hyaluronate |
| Hydrofera LLC | $1,385.27 | 2021-2022 | |
| Medela Ag | $800.00 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $643.80 | 2020-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $452.74 | 2024-2025 | Purified Cortrophin Gel |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orpyx Medical Technologies US INC. | $375.01 | 2022-2023 | Orpyx Si |
| Depuy Synthes Sales INC. | $318.27 | 2021-2025 | Na, Hammerlock |
| Melinta Therapeutics, LLC | $226.16 | 2019-2022 | |
| Nabriva Therapeutics, Plc | $200.73 | 2021-2022 | |
| Sanara Medtech INC. | $190.11 | 2024 | Biasurge |
| Avita Medical Americas, LLC | $180.58 | 2024 | |
| Medela LLC | $165.29 | 2020-2022 | |
| Nevro Corp. | $157.32 | 2022-2024 | Senza |
| Tactile Systems Technology INC | $143.24 | 2020-2025 | Nimbl, Flexitouch Plus |
| Ortho Solutions INC | $133.58 | 2019-2024 | |
| Wright Medical Technology, INC. | $130.81 | 2019-2020 | |
| Convatec INC. | $97.29 | 2021-2025 | |
| Paragon 28, INC. | $88.85 | 2019-2023 | Portfolio, Silverback |
| Mimedx Group, INC. | $61.33 | 2024-2025 | |
| Acera Surgical, INC. | $57.64 | 2022-2025 | Restrata Wound Matrix |
| Amgen INC. | $53.18 | 2025 | Krystexxa |
| Reprise Biomedical, INC. | $48.98 | 2021-2023 | Miro3d |
| Abbott Laboratories | $48.12 | 2019-2021 | |
| Kci USA, INC. | $36.88 | 2021-2023 | 3m Coban, Activ.A.C. |
| Cashflow Solutions, LLC | $35.40 | 2022-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Vertex Pharmaceuticals Incorporated | $35.21 | 2025 | |
| Orthofix Medical, INC. | $29.71 | 2019-2023 | Physio-Stim |
| Horizon Therapeutics Plc | $28.14 | 2022-2023 | Krystexxa |
| Aroa Biosurgery Incorporated | $26.46 | 2019-2020 | |
| Stability Biologics, LLC | $21.87 | 2023 | |
| Ets Wound Care LLC | $20.49 | 2025 | Mirragen Advanced Wound Matrix |
| Cdc Medical LLC | $15.71 | 2022 | |
| Solventum Corporation | $13.69 | 2024 | Activ.A.C. |
| Celularity INC. | $13.00 | 2019 | |
| Alfasigma USA, INC. | $12.53 | 2021 | |
| Allergan, INC. | $11.63 | 2020 | |
| 3m Company | $11.50 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$67,525.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brock Liden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.